Insider · CIK 0001977732
Julie So-Young Kim
Files at TAK (TAKEDA PHARMACEUTICAL CO LTD). First filing Aug 12, 2026, latest Aug 12, 2026.
In brief
Julie So-Young Kim files SEC Form 4 as CEO, president and director at TAK (TAKEDA PHARMACEUTICAL CO LTD). Since Aug 12, 2026, Julie So-Young Kim has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.5M, the latest filed on Aug 12, 2026.
A track record needs three past buys with six months of prices behind them; Julie So-Young Kim has 0, so none is measured yet.
The newest scored trade: sold $1.5M of TAK on Aug 10, 2026, filed Aug 12, 2026, scored 70 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $1.5M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TAK: TAKEDA PHARMACEUTICAL CO LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 70Notable | TAKEDA PHARMACEUTICAL CO LTD | $1.5M 89,090 shares | -19% | +33% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 13, 2026 | TAK Takeda Pharmaceutical Company Limited | 96,558 0.07% of outstanding | $1.6M | Jul 13, 2026 | none |
| Jul 9, 2025 | TAK Takeda Pharmaceutical Company Limited | 58,559 0.05% of outstanding | $903k | Jul 9, 2025 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | SOpen-market sale American Depositary Shares | -89,090 | $17.10 | $1.5M | 391,489 | Aug 12, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award American Depositary Shares | +50,434 | $0.00 | $0 | 480,579 | Jul 6, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Ordinary Shares | +22,800 | $0.00 | $0 | 22,800 | Jul 6, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Tax Obligation Awardderivative | +7,741 | $0.00 | $0 | 7,741 | Jul 6, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Tax Obligation Awardderivative | +7,741 | $0.00 | $0 | 7,741 | Jul 6, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award Tax Obligation Awardderivative | +7,743 | $0.00 | $0 | 7,743 | Jul 6, 2026 |
| Apr 27, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award American Depositary Shares | +105,416 | $0.00 | $0 | 430,145 | Apr 28, 2026 |
Questions about Julie So-Young Kim
Answered from the filings on this page, as of the latest one.
Is Julie So-Young Kim buying or selling?
In the last 12 months Julie So-Young Kim reported 0 open-market buys worth $0 and 1 open-market sell worth $1.5M on SEC Form 4; the latest was sold $1.5M of TAK on Aug 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Julie So-Young Kim's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Julie So-Young Kim has 0.
Where does Julie So-Young Kim file Form 4?
Julie So-Young Kim has filed Form 4 at TAK (TAKEDA PHARMACEUTICAL CO LTD) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.